2020

• IR 2020/11/06

  Notice regarding conclusion of contract with Gene Therapy Research Institution Co., Ltd. to manufacture gene therapy products

• IR 2020/11/06

  Notice regarding revision of full year earnings forecast for the fiscal year ending March 2021

• IR 2020/11/06

  Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31,2021

• IR 2020/11/06

  Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2021

• IR 2020/10/16

  Notice regarding conclusion of comprehensive partnership agreement with Cyfuse Biomedical K.K to manufacture cell products

• IR 2020/10/09

  Notice regarding establishment of Corporate Venture Fund

• IR 2020/09/28

  Notice regarding revision of the first half and full year earnings forecast for the fiscal year ending March 2021

• IR 2020/08/31

  Annual Securities Report for the 74rd business term (April 1, 2019 to March 31, 2020)

• IR 2020/08/31

  Notice regarding acquisition of Treasury Stock

• IR 2020/08/21

  Results Briefing Material for Financial Results fir the First Quarterof the Fiscal Year Ending March 31,2021

• IR 2020/08/21

  Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31,2021

• IR 2020/08/13

  Notice regarding acquisition of Treasury Stock

• IR 2020/08/13

  Notification of the Borrowing of Funds

• IR 2020/08/06

  Notice of Partial correction to “Consolidated Financial Results for the Fiscal Year Ended March 31, 2020 “

• IR 2020/07/13

  Notice regarding Business Transfer and Establishment of a New Subsidiary under our Consolidated Subsidiary

• IR 2020/06/15

  Results Briefing Material for Financial Results for the Fiscal Year Ended March 31, 2020

• IR 2020/06/11

  Consolidated Financial Results for the Fiscal Year Ended March 31,2020

• IR 2020/05/28

  NOTICE OF 74RD ORDINARY GENERAL SHAREHOLDERS’ MEETING

• IR 2020/02/19

  Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31,2020

• IR 2020/02/19

  Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2020

2019

• IR 2019/12/12

  Annual Report 2019

• IR 2019/11/18

  Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31,2020

• IR 2019/11/14

  Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2020

• IR 2019/11/05

  Notification of the Borrowing of Funds　

• IR 2019/11/05

  Notification of the Completion of the Acquisition of New Company Shares and Ownership of the Takatsuki Plant of Daiichi Sankyo Propharma Co., Ltd. (Subsidiary Acquisition)

• IR 2019/08/20

  Results Briefing Material for Financial Results fir the First Quarterof the Fiscal Year Ending March 31,2020

• IR 2019/08/20

  Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31,2020

• IR 2019/08/20

  Annual Securities Report for the 73rd business term (April 1, 2018 to March 31, 2019)

• IR 2019/06/14

  Results Briefing Material for Financial Results for the Fiscal Year Ended March 31,2019

• IR 2019/06/04

  Notification of the Acquisition of a Long-listed Product

• IR 2019/06/04

  Consolidated Financia Results for the Fiscal Year Ended March 31,2019

• IR 2019/05/30

  NOTICE OF 73RD ORDINARY GENERAL SHAREHOLDERS’ MEETING

• IR 2019/03/25

  Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2019

• IR 2019/03/25

  Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2019

• IR 2019/03/25

  Notice of Capital and Business Alliance with Cyfuse Biomedical K.K.

• IR 2019/03/22

  Notice of Investment with Wingo Technology Co.,Ltd.

• IR 2019/02/14

  Concerning acquisition of new company shares and ownership of Daiichi Sankyo Propharma Co., Ltd. Takatsuki Plant (subsidiary acquisition)

• IR 2019/01/08

  Completion of Transfer of Marketing and Manufacturing Rights of 13 Long-Term Listed Products from Chugai to Taiyo Pharma

2018

• IR 2018/12/04

  Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2019

• IR 2018/11/29

  Annual Report 2018

• IR 2018/11/29

  Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2019

• IR 2018/09/05

  Annual Securities Report for the 72nd business term (April 1, 2017 to March 31, 2018)

• IR 2018/08/31

  Shared Research Report has been updated (Q1 FY03/19)

• IR 2018/08/16

  Results Briefing Material for Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2019

• IR 2018/08/16

  Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2019

• IR 2018/08/08

  Shared Research Flash Report has been updated (Q1 FY03/19 Flash Update)

• IR 2018/06/26

  Shared Research Flash Report has been updated (Revision to FY03/18 Results and New Segment Information)

• IR 2018/06/05

  NOTICE OF 72ND ORDINARY GENERAL SHAREHOLDERS’ MEETING

• IR 2018/05/30

  Shared Research Report has been updated (Full-year FY03/18)

• IR 2018/05/22

  Results Briefing Material for Financial Results for the Fiscal Year Ended March 31, 2018

• IR 2018/05/22

  Consolidated Financial Results for the Fiscal Year Ended March 31, 2018

• IR 2018/03/30

  Shared Research Report has been updated (concerning Notice of Revision to Dividend Forecast and A Plan to Buy Back Shares)

• IR 2018/02/14

  Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2018

• IR 2018/02/14

  Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2018

• IR 2018/01/05

  Notice Concerning Execution of Asset Transfer of 13 Long-Term Listed Products from Chugai to Taiyo Pharma

2017

• IR 2017/11/28

  Annual Report 2017 (revised)

• IR 2017/11/28

  Notice Regarding Correction to Taiyo Holdings’ Annual Report 2017

• IR 2017/11/20

  Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2018

• IR 2017/11/20

  Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2018

• IR 2017/11/14

  Marketing and Manufacturing Right Transfer of 13 Long-Term Listed Products from Chugai to Taiyo Pharma

• IR 2017/11/14

  Marketing and Manufacturing Rights Transfer of 13 Long-Term Listed Products

• IR 2017/08/09

  Results Briefing Material for Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2018

• IR 2017/08/09

  Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2018

• IR 2017/06/15

  NOTICE OF 71ST ORDINARY GENERAL SHAREHOLDERS’ MEETING

• IR 2017/06/14

  Notice Concerning Formulation of Medium-Term Business Plan

• IR 2017/05/22

  Results Briefing Material for Financial Results for the Fiscal Year Ended March 31, 2017

• IR 2017/05/22

  Consolidated Financial Results for the Fiscal Year Ended March 31, 2017

• IR 2017/02/07

  Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2017

• IR 2017/02/07

  Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2017

• IR 2017/02/02

  Notice Concerning a Capital and Business Alliance with DIC Corporation, Issuance of New Shares through a Third-party Allotment, Disposition of Treasury Shares, and Changes in Major Shareholders, the Top Shareholder among Major Shareholders, and Associated Companies.

2016

• IR 2016/11/11

  Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2017

• IR 2016/11/11

  Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2017

• IR 2016/11/02

  Annual Report 2016

• IR 2016/08/10

  Results Briefing Material for Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2017

• IR 2016/08/10

  Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2017

• IR 2016/05/17

  Consolidated Financial Results for the Fiscal Year Ending March 31, 2016

• IR 2016/05/17

  Results Briefing Material for Financial Results for the Fiscal Year Ending March 31, 2016

• IR 2016/02/09

  Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2016

• IR 2016/02/09

  Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2016

2015

• IR 2015/12/22

  Annual Report 2015

• IR 2015/11/11

  Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2016

• IR 2015/11/11

  Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2016

• IR 2015/08/07

  Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2016

• IR 2015/08/07

  Results Briefing Material for Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2016

• IR 2015/05/21

  Consolidated Financial Results for the Fiscal Year Ending March 31, 2015

• IR 2015/05/21

  Results Briefing Material for Financial Results for the Fiscal Year Ending March 31, 2015

• IR 2015/02/09

  Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2015

• IR 2015/02/09

  Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2015

2014

• IR 2014/11/17

  Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2015

• IR 2014/11/17

  Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2015

• IR 2014/10/17

  Annual Report 2014

• IR 2014/08/20

  Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2015

• IR 2014/08/20

  Results Briefing Material for Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2015

• IR 2014/05/22

  Results Briefing Material for Financial Results for the Fiscal Year Ending March 31, 2014

• IR 2014/05/22

  Consolidated Financial Results for the Fiscal Year Ending March 31, 2014

• IR 2014/02/17

  Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2014

• IR 2014/02/17

  Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2014

2013

• IR 2013/12/06

  Annual Report 2013

• IR 2013/11/26

  Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2014

• IR 2013/11/26

  Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2014

• IR 2013/08/27

  Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2014

• IR 2013/08/27

  Results Briefing Material for Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2014

• IR 2013/05/27

  Consolidated Financial Results for the Fiscal Year Ending March 31, 2013

• IR 2013/05/27

  Results Briefing Material for Financial Results for the Fiscal Year Ending March 31, 2013

• IR 2013/02/19

  Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2013

• IR 2013/02/14

  Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2013

2012

• IR 2012/11/22

  Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2013

• IR 2012/11/22

  Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2013

• IR 2012/10/19

  Annual Report 2012

• IR 2012/08/09

  Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2013

• IR 2012/08/09

  Results Briefing Material for Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2013

• IR 2012/05/30

  Consolidated Financial Results for the Fiscal Year Ending March 31, 2012

• IR 2012/05/30

  Results Briefing Material for Financial Results for the Fiscal Year Ending March 31, 2012

• IR 2012/02/17

  Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2012

• IR 2012/02/17

  Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2012

2011

• IR 2011/11/22

  Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2012

• IR 2011/11/17

  Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2012

• IR 2011/09/09

  Annual Report 2011

• IR 2011/09/01

  Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2012

• IR 2011/08/09

  Results Briefing Material for Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2012

• IR 2011/05/30

  Consolidated Financial Results for the Fiscal Year Ended March 31, 2011

• IR 2011/05/30

  Results Briefing Material for Financial Results for the Fiscal Year Ended March 31, 2011

• IR 2011/02/18

  Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2011

• IR 2011/02/18

  Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2011

2010

• IR 2010/12/10

  Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2011

• IR 2010/12/10

  Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2011

• IR 2010/08/27

  Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2011

• IR 2010/08/27

  Results Briefing Material for Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2011

• IR 2010/07/06

  Notice of Transition to the Holding Company System through a Company Split and Amendments to the Articles of Incorporation. (Partial Amendment of the Corporate Name and Purpose)

• IR 2010/06/14

  Consolidated Financial Results for the Fiscal Year Ended March 31, 2010

• IR 2010/06/14

  Results Briefing Material for Financial Results for the Fiscal Year Ended March 31, 2010

• IR 2010/05/17

  Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2010

• IR 2010/05/17

  Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2010

2009

• IR 2009/11/19

  Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2010

• IR 2009/11/19

  Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2010

• IR 2009/09/02

  Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2010

• IR 2009/09/02

  Results Briefing Material for Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2010

• IR 2009/06/19

  Consolidated Financial Results for the Fiscal Year Ended March 31, 2009

• IR 2009/06/19

  Results Briefing Material for Financial Results for the Fiscal Year Ended March 31, 2009

• IR 2009/03/03

  Consolidated Financial Results for the Nine Months of the Fiscal Year Ending March 31, 2009

• IR 2009/03/03

  Results Briefing Material for Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2009

2008

• IR 2008/12/12

  Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2009

• IR 2008/12/12

  Results Briefing Material for Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2009

• IR 2008/08/13

  Results Briefing Material for Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2009